[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100333698":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":19,"responsibleParty":39,"collaborators":41,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":10,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":10,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"University Hospital Tuebingen","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"uterine neoplasms",null,"Women with operable and inoperable uterine malignomas (cervical cancer, endometrial cancer, uterine sarcoma)",[13],"Diagnostic Test: uterine neoplasms",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":10},"DIAGNOSTIC_TEST","Analysis of circulating (CTC) and disseminating tumor cells (DTC), determination of Human Papilloma Virus (HPV), Douglas cytology, DNA analysis in blood, proteome analysis, sentinel lymph node detection",[9],[20],{"facility":21,"status":22,"city":23,"state":10,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"University Hospital Tuebingen, Department of Women's Health","RECRUITING","Tübingen","72076","Germany","DE",{"type":28,"coordinates":29},"Point",[30,31],9.05222,48.52266,{"lat":31,"lon":30},[34],{"name":35,"role":36,"phone":37,"phoneExt":10,"email":38},"Miriam Linneweh, Dr","CONTACT","+4970712982211","miriam.linneweh@med.uni-tuebingen.de",{"type":40,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[42,44,46],{"name":43,"class":6},"University Hospital Heidelberg",{"name":45,"class":6},"University of Homburg",{"name":47,"class":6},"University Hospital Freiburg","100333698","analysis-and-optimization-of-predictive-and-therapeutic-models-in-uterine-neoplasms-100333698",false,"NCT03624712","Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms","Prospective, Tricentric Open Trial on the Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms","Inclusion Criteria:\n\n* Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma)\n* If operable: surgical primary therapy: laparoscopic\u002Frobot-assisted or open radical gyneco-oncological surgery\n* Written consent\n* Willingness and ability to participate in all study-specific procedures\n* Age ≥ 18 years\n\nExclusion Criteria:\n\n* Severe and acute general disease in the last 4 weeks\n* Acute or chronic psychiatric disorders\n* Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)","FEMALE","18 Years",{"count":58,"type":59},580,"ESTIMATED","OBSERVATIONAL","Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm",[63],"Uterine Neoplasms","2025-01-15",{"date":66,"type":67},"2025-01-17","ACTUAL",{"date":69,"type":67},"2012-01",{"date":71,"type":59},"2027-12",{"name":5,"class":6},1]